Cargando…

Therapeutic Effects of Kefir Peptides on Hemophilia-Induced Osteoporosis in Mice With Deficient Coagulation Factor VIII

Osteoporosis is a clinically prevalent comorbidity in patients with hemophilia. A preventive effect of kefir peptides (KPs) on postmenopausal osteoporosis has been proved. The aim of this study was to evaluate the therapeutic effect of KPs for the treatment of osteoporosis in coagulation factor VIII...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yen, Chih-Ching, Liu, Yao-Wen, Chang, Gary Ro-Lin, Lan, Ying-Wei, Kao, Yung-Tsung, Cheng, Shin-Nan, Chen, Wei, Chen, Chuan-Mu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Cell and Developmental Biology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8894723/ https://www.ncbi.nlm.nih.gov/pubmed/35252176 http://dx.doi.org/10.3389/fcell.2022.794198

Ejemplares similares

Kefir peptides attenuate atherosclerotic vascular calcification and osteoporosis in atherogenic diet-fed ApoE (−/−) knockout mice
por: Chang, Gary Ro-Lin, et al.
Publicado: (2023)

Novel Coagulation Factor VIII Gene Therapy in a Mouse Model of Hemophilia A by Lipid-Coated Fe(3)O(4) Nanoparticles
por: Kao, Yung-Tsung, et al.
Publicado: (2021)

Investigating Optimal Autologous Cellular Platforms for Prenatal or Perinatal Factor VIII Delivery to Treat Hemophilia A
por: Stem, Christopher, et al.
Publicado: (2021)

Additive Antiproliferative and Antiangiogenic Effects of Metformin and Pemetrexed in a Non-Small-Cell Lung Cancer Xenograft Model
por: Wang, Jiun-Long, et al.
Publicado: (2021)

In Utero Cell Treatment of Hemophilia A Mice via Human Amniotic Fluid Mesenchymal Stromal Cell Engraftment
por: Kao, Yung-Tsung, et al.
Publicado: (2023)

Potentiation of Thrombin Generation in Hemophilia A Plasma by Coagulation Factor VIII and Characterization of Antibody-Specific Inhibition
por: Doshi, Bhavya S., et al.
Publicado: (2012)

Suppression of Dendritic Cell Maturation by Kefir Peptides Alleviates Collagen-Induced Arthritis in Mice
por: Chen, Chien-Fu, et al.
Publicado: (2021)

Compensated pathogenic variants in coagulation factors VIII and IX present complex mapping between molecular impact and hemophilia severity
por: Marín, Òscar, et al.
Publicado: (2019)

The Roles of Epigenetics Regulation in Bone Metabolism and Osteoporosis
por: Xu, Fei, et al.
Publicado: (2021)

Endothelial cells derived from patients' induced pluripotent stem cells for sustained factor VIII delivery and the treatment of hemophilia A
por: Rose, Melanie, et al.
Publicado: (2020)

Novel Kefir Exopolysaccharides (KEPS) Mitigate Lipopolysaccharide (LPS)-Induced Systemic Inflammation in Luciferase Transgenic Mice through Inhibition of the NF-κB Pathway
por: Liao, Chun-Huei, et al.
Publicado: (2023)

CRISPR/Cas9-Mediated in vivo Genetic Correction in a Mouse Model of Hemophilia A
por: Luo, Sanchuan, et al.
Publicado: (2021)

Hesperidin Ameliorates Dexamethasone-Induced Osteoporosis by Inhibiting p53
por: Zhang, Meng, et al.
Publicado: (2022)

Fish Models of Induced Osteoporosis
por: Rosa, Joana T., et al.
Publicado: (2021)

Integrative Analysis for Elucidating Transcriptomics Landscapes of Glucocorticoid-Induced Osteoporosis
por: Ying, Xiaoxia, et al.
Publicado: (2020)

Comprehensive Analysis of the Genetic and Epigenetic Mechanisms of Osteoporosis and Bone Mineral Density
por: Dong, Hui, et al.
Publicado: (2020)

Mechanisms of estrogen deficiency-induced osteoporosis based on transcriptome and DNA methylation
por: Xu, Ziying, et al.
Publicado: (2022)

Urinary extracellular vesicles carry multiple activators and regulators of coagulation
por: Saraswat, Mayank, et al.
Publicado: (2022)

The Relationship Between Osteoporosis and Intestinal Microbes in the Henan Province of China
por: Qin, Qian, et al.
Publicado: (2021)

m6A demethylase FTO and osteoporosis: potential therapeutic interventions
por: Huang, Mei, et al.
Publicado: (2023)

The role of circadian rhythm in osteoporosis; a review
por: Tian, Yihao, et al.
Publicado: (2022)

Postpartum Acquired Hemophilia Factor VIII Inhibitors and Response to Therapy
por: Karakuş, Volkan, et al.
Publicado: (2012)

Idiopathic Acquired Hemophilia A with Undetectable Factor VIII Inhibitor
por: Abt, Nicholas B., et al.
Publicado: (2014)

The factor VIII treatment history of non‐severe hemophilia A
por: Abdi, Amal, et al.
Publicado: (2020)

FACTOR VIII COAGULANT ACTIVITY AND FACTOR VIII-LIKE ANTIGEN: INDEPENDENT MOLECULAR ENTITIES
por: Zimmerman, Theodore S., et al.
Publicado: (1973)

Kefir
Publicado: (1884)

Kefir
Publicado: (1887)

Short-Term Effects of Kefir-Fermented Milk Consumption on Bone Mineral Density and Bone Metabolism in a Randomized Clinical Trial of Osteoporotic Patients
por: Tu, Min-Yu, et al.
Publicado: (2015)

Restoration of FVIII Function and Phenotypic Rescue in Hemophilia A Mice by Transplantation of MSCs Derived From F8-Modified iPSCs
por: Qiu, Liyan, et al.
Publicado: (2021)

Folic Acid Attenuates High-Fat Diet-Induced Osteoporosis Through the AMPK Signaling Pathway
por: He, Haiting, et al.
Publicado: (2022)

Polydatin Ameliorates Osteoporosis via Suppression of the Mitogen-Activated Protein Kinase Signaling Pathway
por: Lin, Ze, et al.
Publicado: (2021)

Effect of Kefir on Soybean Isoflavone Aglycone Content in Soymilk Kefir
por: Yang, Minke, et al.
Publicado: (2020)

SPTBN1 Prevents Primary Osteoporosis by Modulating Osteoblasts Proliferation and Differentiation and Blood Vessels Formation in Bone
por: Xu, Xuejuan, et al.
Publicado: (2021)

Kefir Peptides Prevent Estrogen Deficiency-Induced Bone Loss and Modulate the Structure of the Gut Microbiota in Ovariectomized Mice
por: Tu, Min-Yu, et al.
Publicado: (2020)

HO-1 in Bone Biology: Potential Therapeutic Strategies for Osteoporosis
por: Zhou, Xueman, et al.
Publicado: (2021)

Treatment of Hemophilia A Using Factor VIII Messenger RNA Lipid Nanoparticles
por: Chen, Chun-Yu, et al.
Publicado: (2020)

Uncovering Hidden Mechanisms of Different Prescriptions Treatment for Osteoporosis via Novel Bioinformatics Model and Experiment Validation
por: Liu, Yujie, et al.
Publicado: (2022)

Innovative Approaches for Immune Tolerance to Factor VIII in the Treatment of Hemophilia A
por: Sherman, Alexandra, et al.
Publicado: (2017)

Hemophilia and von Willebrand disease: Factor VIII and von Willebrand factor
por: Sharma, Prashant
Publicado: (2019)

Factor VIII: Perspectives on Immunogenicity and Tolerogenic Strategies for Hemophilia A Patients
por: Khalilian, Sheyda, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_rbjssgn0hc43n09hntc2ibjlbm